Building a well-oiled clinical trial supply chain that fulfills the requirements of Phase I and II pharmaceutical clinical trials does not happen by accident. It is universally understood that clinical trial material (CTM) manufacturing demands a commitment to Good Clinical Practice and current Good Manufacturing Practice (cGMP). These guidelines were developed in concert by the [...]The post Clinical Trial Material Manufacturing in an Age of Increasing Regulatory Oversight appeared first on VxP Pharma.